-
Cotation en bourse
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
Introduction en bourse de Lysogène
08/02/2017
Introduction en bourse de Lysogène sur Euronext
Karen Aiach, Fondatrice et Directeur Général, Lysogène, sonne la cloche qui marque l'ouverture des marchés à Paris.
Lysogene est une société de biotechnologies spécialisée dans la recherche et le développement de thérapies géniques destinées au traitement des maladies neurodégénératives rares. La société dispose de 2 produits en phase de développement pour le traitement de la maladie de Sanfilippo et de la gangliosidose.